1. Gale HB, Gitterman SR, Hoffman HJ et al. Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts >=300 cells/μL and HIV-1 suppression? Clin Infect Dis. 2013; 56:1340-3.
  2. McBride JA, Striker R. Imbalance in the game of T cells: What can the CD4/CD8 T-cell ratio tell us about HIV and health? PLoS Pathog. 2017; 13:e1006624.
  3. Eggena MP, Barugahare B, Okello M et al. T cell activation in HIV-seropositive Ugandans: Differential associations with viral load, CD4(+) T cell depletion, and coinfection. Journal of Infectious Diseases 2005; 191:694-701.
  4. Karim R, Mack WJ, Stiller T, Operskalski E et al. Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach. AIDS. 2013; 27:1473-81.
  5. Hunt PW, Cao HL, Muzoora C et al. Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS. 2011; 25:2123-31
  6. Lewis J, Payne H, Walker S et al. Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial. Front. Immunol. 2017; 8:1162.
  7. Chattopadhyay PK, Douek DC, Gange SJ et al. Longitudinal assessment of de novo T cell production in relation to HIV‐associated T cell homeostasis failure. AIDS Res Hum Retroviruses 2006; 22: 501-507.
  8. D'Orsogna LJ, Krueger RG, McKinnon EJ et al. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy. AIDS. 2007; 21:1747-52.